These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The use of cyclosporine in dermatology.
    Author: Dehesa L, Abuchar A, Nuno-Gonzalez A, Vitiello M, Kerdel FA.
    Journal: J Drugs Dermatol; 2012 Aug; 11(8):979-87. PubMed ID: 22859244.
    Abstract:
    Cyclosporine is an immunosuppressive drug that acts selectively on T-cells by inhibiting calcineurin phosphorylase. It has been used in dermatology since its approval for US Food and Drug Administration in 1997 for the use in psoriasis. While indicated only for the treatment of moderate to severe psoriasis, cyclosporine has also been used as an off-label drug for the treatment of various inflammatory skin conditions, including atopic dermatitis, blistering disorders, and connective tissue diseases. In this article, we review the use of cyclosporine in dermatology.
    [Abstract] [Full Text] [Related] [New Search]